The purpose of the study was to compare the efficacy of 2 different Etanercept regimens for the treatment of skin and joint manifestations of psoriatic arthritis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
752
Number of Patients Achieving "Clear" or "Almost Clear" on Physician Global Assessment (PGA) of Psoriasis
The PGA of Psoriasis scale ranges from 0 (no psoriasis) to 5 (severe disease). "Clear" and "Almost Clear" includes all patients who were scored as a 0 or 1.
Time frame: 12 weeks
Number of Patients Achieving Psoriatic Arthritis Response Criteria (PsARC)
The PsARC response was defined as improvement in at least 2 of the four criteria: \>=30% decrease in swollen joint count, \>=30% decrease in tender joint count, \>=20% improvement in patient's Global Assessment of Disease Activity (arthritis) using VAS (0-100 mm, 0=excellent and 100= poor), \>=20% improvement in physician's Global Assessment of Disease Activity using VAS (VAS: 0-100 mm, 0=no arthritis activity and 100=extremely active arthritis), and at least one of the 2 joint criteria with no deterioration in the other criteria.
Time frame: 12 and 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital A Posadas
Palomar, Buenos Aires, Argentina
Hospital General de Agudos
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
CEMIC
Buenos Aires, Argentina
Hospital General de Agudos
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
Instituto de Medicina Cutanea
Buenos Aires, Argentina
Goulburn Street Medical Centre
Liverpool, New South Wales, Australia
St Vincent's Hospital VIC
Fitzroy, Australia
Universitaetsklinik Graz
Graz, SM, Austria
...and 110 more locations